SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001395064-24-000004
Filing Date
2024-01-19
Accepted
2024-01-19 06:03:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13G sc13g_011924.htm SC 13G 65270
2 EX-99.1 exhibit991_011924.htm EX-99.1 1939
3 EX-99.2 exhibit992_011924.htm EX-99.2 6780
  Complete submission text file 0001395064-24-000004.txt   75617
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Subject) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90684 | Film No.: 24543638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)